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SUMMARY 
 
Background: A correct preanalytical phase procedure is critical to get an adequate sample and consequently to 
achieve the most reliable laboratory results, promoting patient safety. Continuous laboratory staff changes create 
the need to establish improvement strategies to reduce the error risk. The objective was to show how the numbers 
of preanalytical errors related to unsuitable samples in a hospital setting decrease following two improvement 
strategies related to new technology and educational actions and how their effects were measured by monitoring 
indicators. 
Methods: Samples were drawn by the laboratory and other hospital departments’ nurses without previous patient 
appointment, therefore, prior tube preparation was not available before the phlebotomy. Corrective measures for 
these activities were established: educational program for nurses and a system of custom labels, which correlate 
each laboratory test in the Laboratory Information System (LIS) with the corresponding tube. Three phases were 
defined based on the implementation dates of the improvement actions to be assessed. The set of indicators de-
signed to monitor the improvement related to clotted, hemolyzed, insufficient, and uncollected samples. Data were 
collected and indicators calculated from the LIS using a data warehouse application. Patient satisfaction with re-
spect to phlebotomy was also measured annually using a scoring survey. 
Results: There was a reduction in all types of preanalytical sample errors related to the improvement strategies 
adopted. The indicators demonstrated that the unavailable, insufficient, and clotted samples decreased between 
two- and three-fold, whereas hemolysis errors benefited more from these improvement strategies.  
Patient satisfaction with the laboratory and phlebotomy procedures improved over the past several years as based 
on the annual satisfaction surveys.  
Conclusions: The educational program for nursing personnel is relevant and important as can be seen in the de-
crease of sample errors and the resulting quality improvement. The custom label system minimizes the potential 
oversight of forgetting to draw a tube, which happens frequently when operating without appointments, by print-
ing the labels according to requested tests. Detection, identification, and monitoring of the error and implement-
ing strategies to improve preanalytical quality reduces error numbers and thereby improves patient safety and 
health system outcomes. 
(Clin. Lab. 2012;58:xx-xx. DOI: 10.7754/Clin.Lab.2012.111111)  
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INTRODUCTION 
 
Clinical laboratory sample analysis is very important in 
health care, as it leads to results that affect clinical as-
pects regarding the patient's diagnosis, treatment or 
health status follow up. The laboratory report has an in-
fluence on 60 - 70% of clinical decisions made. [1] 
R. LILLO et al. 
Clin. Lab. 9+10/2012 2 
The clinical laboratory’s main objective should be de-
livering quality results achieved through an appropriate 
and standardized sample treatment throughout the entire 
process, from the beginning of sample collection to the 
delivery and communication of the laboratory report. 
The daily laboratory professional challenge must be to 
minimize the possible errors at any phase during this 
process. Therefore corrective measures must be applied, 
if necessary, and subsequent evaluation of the improve-
ment is essential. 
The analytical process is a set of consecutive tasks, im-
proving each phase to be as effective as possible to en-
hance the quality and efficiency in the organization.  
Nowadays, the testing process still requires extensive 
manual management through the different laboratory 
procedures (pre-, intra- and post-analytical) which car-
ries a percentage of error risk. A laboratory error was 
defined by the International Organization for Standard-
ization (ISO) as “any failure of planned action to be 
completed as intended, or use a wrong plan to achieve 
an aim, occurring at any part of the laboratory cycle, 
from ordering examinations to reporting results and ap-
propriately interpreting and reacting to them” [2]. The 
main laboratory error source is the preanalytical phase, 
where the phlebotomy and subsequent sample distribu-
tion are carried out, actions that are fundamentally man-
ual. “According to reliable data, preanalytical errors still 
account for nearly 60 – 70% of all problems occurring 
in laboratory, most of them attributable to mishandling 
procedures during collection, handling, preparing or 
storing the specimens” [3]. Substantial advances in 
technology, automation, and analytical quality over time 
has improved laboratory performance, while at the same 
time has increased the absolute amount of laboratory re-
ports. However, automation implementation is not ex-
pected to exert a substantial influence on phlebotomy 
errors. It is necessary to establish different strategies to 
prevent the weakness in this crucial procedure. Frequent 
turnover of the nurses performing phlebotomies and 
“shortages of skilled staff and overloaded systems cre-
ate new occasions for basic but easily preventable errors 
that might compromise patient safety and introduce un-
justified health expenditure” [4].  
Other issues that must be taken into account to ensure 
proper collecting of patient samples is the patient identi-
fication and number of samples to be drawn. “The pre-
analytic phase enfolds the greatest potential for quality 
improvement, once reliable strategies are identified and 
applied” [5]. The laboratory strategy must begin by cre-
ating an error identification policy, monitored with indi-
cators [6], and the development of improvement strate-
gies for their reduction [7]. 
The study objective was to show how the number of 
preanalytical errors related to unsuitable samples in a 
hospital setting decrease following two improvement 
strategies established usig new technology and educa-
tion, and how their effects were measured by monitor-
ing with indicators. 
 
MATERIALS AND METHODS 
 
The study was carried out in the Laboratory of the San 
Juan Hospital in Alicante, which serves a population of 
234551 inhabitants and is highly targeted to oncology 
patients. The laboratory attends in and outpatients and 
also receives primary care patient samples obtained in 
Primary Care Centers, which are transported to the hos-
pital laboratory.  
This study focuses on outpatients’ samples that were 
drawn by the laboratory nurses and supported by nurses 
from other hospital departments. 
Outpatients’ samples were obtained without previous 
patient appointment so prior preparation of the tubes 
was not possible before the phlebotomy representing a 
possible source of error in the sequential preanalytical 
process.  
The impact of two improvement actions aimed at re-
ducing the amount of errors in our hospital/laboratory 
were measured. 
The study period was established from July 2007 - July 
2010 and three phases were defined (Aug 2007 - Jan 
2008; Feb 2008 - Oct 2009; and Nov 2009 - Jul 2010), 
based on the dates of implementation of the improve-
ment actions, in order to evaluate their effectiveness. In 
January 2008, a system of custom labels was estab-
lished for each patient request. Each laboratory test in 
the Laboratory Information System (LIS) was associ-
ated with a corresponding tube. When a request was 
registered, the tube’s identifying labels were printed in 
accordance with the tests requested. In October 2009, a 
host plan was set up for nursing personnel attending the 
laboratory for the first time. This consisted of an infor-
mative leaflet (Figure 1) describing the laboratory sam-
ple drawing procedure and encouraging them to ask for 
help from coworkers, if needed. The host plan was ex-
plained by the laboratory nurse supervisor to each nurse 
on the first day of work, clearing any doubts, and as-
signing an expert coworker to monitor the new nurse 
daily during the first month.  
A sample error was defined as a rejected specimen: any 
blood or urine sample which cannot be successfully 
tested as it does not meet the laboratory acceptability 
criteria or if the sample is not collected [8]. 
Preanalytical errors were seen in tests requested for he-
matology (EDTA tube), coagulation (citrate tube), che-
mistry (serum tube), and urine samples. Specimens that 
were clotted, insufficient, hemolyzed or uncollected 
(sample needed for processing requested tests, but not 
collected) were included.  
In the hematology and coagulation samples, clotted, in-
sufficient, and uncollected samples were seen as errors. 
In the chemistry samples, errors were hemolyzed and 
uncollected samples and in the urine samples, the only 
error considered was uncollected.  
When an unsuitable sample is identified, a specificly 
coded result was registered in the LIS as the test result 
in order to report the incident and to request a new sam- 
ple. Such coded results (preanalytical errors) were iden-
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Figure 1. Informative leaflet of the host plan at the Clinical Laboratory for nursing professionals. 
 
The figure shows the informative leaflet, integrated into the host plan, which is given to the nursing professionals upon their arrival to the 
laboratory. 
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Figure 2.  Evolution of errors by periods studied and improvement actions (cases/10000 samples). 
 
The figure shows the errors in each sample type, expressed in cases/10000 samples during the periods studied in accordance with the improve-
ment actions implemented. 
Abbreviations: CS: clotted sample; IS: insufficient sample; US: unavailable sample; HS: hemolyzed sample. 
 
 
 
 
 
tified and collected automatically from the LIS. 
To establish the improvement strategies, monthly indi-
cators were designed and classified as individual and 
global. Individual indicators represent each type of pre-
analytical error with respect to every sample collected 
(three in hematology and coagulation, two in chemistry, 
and one in urine samples). Global indicators represent 
the sum of all types of preanalytical errors with respect 
to every sample collected (there are three; urine is the 
same for global and individual). 
The indicators were collected and calculated using a 
software program based on Data Warehouse and On-
Line Analytical Processing (OLAP) cube (Data Ware-
house Omnium® Roche Diagnostics). The number of 
errors per 10000 samples was calculated. The decrease 
in the risk of error was also calculated by dividing the 
number of errors in the first period (preceding the im-
provement actions) by the number of errors that oc-
curred in the last period. The graphic representation of 
the indicator results is shown in Microsoft Excel 
2003®.  
Patient satisfaction with respect to phlebotomy was 
measured annually through customer satisfaction sur-
veys, which were evaluated on a scale of 0 to 10 (0, 
poor and 10, excellent). The survey contains 16 ques-
tions 6 refer to the phlebotomy room (cleanliness, com- 
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Figure 3. Evolution of errors as a function of each sample type according to periods studied and improvement actions 
(cases/10000 samples). 
 
The figure shows the errors for each type of sample expressed in cases/10000 samples during the periods studied in accordance 
with the improvement actions implemented.  
Abbreviations: CS: clotted sample; IS: insufficient sample; US: unavailable sample; HS: hemolyzed sample. 
 
 
 
 
fort ...), 6 to the drawing procedure, 3 refer to the labo-
ratory administrative staff that registers the patient’s da-
ta, and finally one question evaluates the overall ser-
vice. 
During the study period, there were no other technolog-
ical or procedural changes for the shown improve-
ments.  
 
 
 
 
RESULTS 
 
During the study period (from July 2007 - July 2010) 
136,479 requests and 2,296,695 tests were received.  
In the first phase (Aug 2007 - Jan 2008), 16602 theo-
retical hematology, 5300 coagulation, 12383 chemistry, 
and 2248 urine samples were registered. In the second 
phase (Feb 2008 - Oct 2009), 60574, 19777, 44896, and 
8686 samples, respectively, were registered as well; 
during the third phase (Nov 2009 - Jul 2010), 21708, 
7067, 15444, and 2673, respectively, were registered. 
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The most frequent error in hematology tubes was a clot-
ted sample, while for coagulation and chemistry it was 
an unavailable sample. The risk of committing each 
type of error for each type of sample diminished follow-
ing the implementation of the improvement actions as 
evidenced in the study evolution. 
The results are graphically shown (Figure 2) in four 
graphics, one for each type of sample: samples of hema-
tology (Figure 2A), coagulation (Figure 2B), chemistry 
(Figure 2C), and urine (Figure 2D). In all graphics the 
baseline for laboratory preanalytical errors can be seen 
and then the decrease with the first improvement action 
(custom labels) and finally the effect of both (custom 
labels and host plan) following the establishment of the 
host plan. 
Preanalytical error evolution is observed and expressed 
in cases per 10000 samples. Figure 3 also shows the im-
provement in the global indicators after the two inter-
ventions. The risk of committing an error after imple-
menting the improvement actions diminished in all 
cases, reaching 8.16 times for the chemistry sample. 
Patient satisfaction with laboratory attendance and phle-
botomy procedure has improved over the past several 
years (average scores 7.9, 8, 8.3, and 8.3 since 2007). 
Annual results (average score) since 2007 are shown. 
 
 
DISCUSSION 
 
Three basic pillars exist for improving patient safety 
from the laboratory. The first one is the improvement in 
the clinician-laboratory professional interface in order 
to obtain improvements in test requests as much as in 
report interpretation, i.e. redirecting the laboratory to-
wards a customer service team. Second is the continu-
ous improvement in analytical quality; even though few 
errors are described in this stage, these are the ones that 
carry the highest risk [9]. Lastly, improving preanalyt-
ical quality, because this is where most errors are de-
scribed [3] but at the same time, this is where they are 
most easily avoidable. Hence, laboratories must be en-
couraged focus on continuous improvement in preana-
lytical quality [10]. 
Some errors may be due to poor communication, action 
taken by others involved in the testing process (e.g., 
physicians, nurses, and phlebotomists), or a poorly de-
signed-process, all which are beyond the laboratory´s 
control [1]. Preanalytical errors caused by unsuitable 
samples resulting from defective sampling procedure 
can be serious and cause an inadequate result in diagno-
sis, treatment or prevention [11]. These errors can also 
be null or minor and provoke diagnostic delay or patient 
discomfort, like a second phlebotomy [3], creating the 
need to establish appropriate measures for their reduc-
tion. It is necessary to detect, identify, and monitor the 
error in an automated and continuous manner over time 
[1]. Standardization and monitoring preanalytical vari-
ables is of foremost importance and is associated with 
the most efficient and well-organized laboratories, re-
sulting in reduced operational costs and increased reve-
nues [12]. 
It is important to be aware of any changes that may in-
crease laboratory errors and accordingly establish cor-
rective measures trying to increase patient safety. Al-
though human conditions cannot be changed, the con-
ditions under which humans work and can be controled 
and can be improved upon [2]. Historically, phlebotomy 
was always performed by laboratory personnel. How-
ever, the gradual arrival of laboratory technicians has 
led to progressive disappearance of laboratory nurses 
responsible for sampling procedures. Phlebotomy suc-
cess, a critical prerequisite for suitable specimens, is de-
pendent upon the degree of laboratory supervision of 
this procedure [4]. This created the need for corrective 
measures to be applied. 
The fact that patients do not have appointments for the 
laboratory does not allow for prior LIS patient registra-
tion or prior preparation of the tubes that nurses have to 
draw for each patient. This is a clear cause of the “not 
collected” samples due to personnel. 
The custom label system has managed to avoid missing 
samples by printing labels according to the requested 
tests.  
The big difference between IS and US in coagulation 
samples as compared with the same errors in haematol-
ogy, could be explained by the limited coagulation tests 
requested that leads to forgetfulness. However, com-
plete blood count is requested almost systematically in 
every patient. 
The study makes use of daily testing laboratory regis-
ters that are indispensable in providing unsuitable test 
specimen results to construct the indicators. The collec-
tion of the LIS registers and the calculation of the indi-
cators are carried out automatically and in real time 
with a computer application based on Data Warehouse. 
This implies three great advantages: there are no regis-
ter losses and there is continuous collection and acquisi-
tion of the preanalytical quality indicators in real time 
without any additional effort.  
The study results demonstrate that the two improvement 
actions implemented in the laboratory have reduced the 
number of errors in the two periods of the study. The 
various indicators studied show how the unavailable, in-
sufficient, and clotted samples decreased between two 
and three times, whereas errors from hemolysis im-
proved by a much greater proportion, and this is the er-
ror that benefits more from these improvement actions.  
The sample drawing procedure is especially sensitive to 
technical problems; it is the only moment the patient is 
in contact with the laboratory personnel, and as such, it 
requires special attention. The training, ability, and im-
plication of the professionals is fundamental. As the stu-
dy results show, the host plan for nursing personnel is 
both relevant and very important with regards to the de-
crease in errors and the resulting quality improvement. 
Patients have become more satisfied with attendance 
laboratory and phlebotomy procedure every year, as can 
be seen in the annual satisfaction surveys.  
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The issuance of custom labels minimizes the potential 
oversight of forgetting to draw a sample, which happens 
frequently when we are operating without appointments 
where neither prior LIS patient registration nor prior 
preparation of the tubes is possible. 
It is very difficult to answer whether it is worth more to 
improve technical circumstances or staff training to 
minimize particular errors based on the study data. But 
what is certain is that the drawing procedure is the only 
moment the patient contacts the laboratory and it is 
therefore essential to establish the maximum number of 
improvement strategies 
The laboratory is involved in many medical procedures, 
and therefore small efforts can lead to large results. 
Laboratory professionals, as demonstrated in this study, 
must take advantage of all the tools available within 
their reach [13,14], whether they are technological or 
training [15] in order to identify and diminish the error 
[16] throughout the entire process and promote continu-
ous improvement which will always benefit patient 
safety [3]. 
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